Onyx Pharmaceuticals, Inc., an Amgen subsidiary
Cancer therapy development
- B2B
About Onyx Pharmaceuticals, Inc., an Amgen subsidiary
A company specializing in developing and commercializing innovative cancer therapies to improve patients' lives, acquired by Amgen in 2013
Key facts
- Industry
- Biotechnology
- Company size
- 51–250 employees
- Headquarters
- South San Francisco, California, United States
- Founded
- 1991
- Revenue
- $19.6M – $154MTamtam estimate
- Website
- amgen.com
Onyx Pharmaceuticals, Inc., an Amgen subsidiary at a glance
Onyx Pharmaceuticals, Inc., an Amgen subsidiary is a B2B company in the Biotechnology industry, headquartered in South San Francisco, California, United States.
Onyx Pharmaceuticals, Inc., an Amgen subsidiary was founded in 1991.
Onyx Pharmaceuticals, Inc., an Amgen subsidiary has 51–250 employees.
Onyx Pharmaceuticals, Inc., an Amgen subsidiary's revenue is $19.6M – $154M (Tamtam estimate).
Frequently asked questions about Onyx Pharmaceuticals, Inc., an Amgen subsidiary
What is Onyx Pharmaceuticals, Inc., an Amgen subsidiary's revenue?
Tamtam estimates Onyx Pharmaceuticals, Inc., an Amgen subsidiary's annual revenue at $19.6M – $154M.
How many employees does Onyx Pharmaceuticals, Inc., an Amgen subsidiary have?
Onyx Pharmaceuticals, Inc., an Amgen subsidiary has 51–250 employees.
Where is Onyx Pharmaceuticals, Inc., an Amgen subsidiary headquartered?
Onyx Pharmaceuticals, Inc., an Amgen subsidiary is headquartered in South San Francisco, California, United States.
Selling to companies like Onyx Pharmaceuticals, Inc., an Amgen subsidiary?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies